Search research articles
Contact Us
Filters
Showing results (81-90 of 133) with videos related to
Page
of 14
Sort By:
Research and Practice in Thrombosis and Haemostasis
|
April 3, 2025
Elderly patients are hyperresponsive to potent P2Y12 inhibitors
David Mutschlechner, Maximilian Tscharre, Patricia Pia Wadowski, et al.
Thrombosis Research
|
April 30, 2013
Response to antiplatelet therapy is independent of endogenous thrombin generation potential
Thomas Gremmel, Simon Panzer, Sabine Steiner, et al.
Platelets
|
July 14, 2010
Is TRAP-6 suitable as a positive control for platelet reactivity when assessing response to clopidogrel?
Thomas Gremmel, Andreas Calatzis, Sabine Steiner, et al.
Frontiers in Cardiovascular Medicine
|
January 8, 2021
Association of Soluble Suppression of Tumorigenesis 2 (sST2) With Platelet Activation, Monocyte Tissue Factor and Ischemic Outcomes Following Angioplasty and Stenting
Stefan Stojkovic, Svitlana Demyanets, Christoph W Kopp, et al.
Atherosclerosis
|
April 19, 2011
The P-selectin gene Pro715 allele and low levels of soluble P-selectin are associated with reduced P2Y12 adenosine diphosphate receptor reactivity in clopidogrel-treated patients
Thomas Gremmel, Christoph W Kopp, Sabine Steiner, et al.
Thrombosis Research
|
December 14, 2011
Influence of cytochrome 2C19 allelic variants on on-treatment platelet reactivity evaluated by five different platelet function tests
Thomas Gremmel, Christoph W Kopp, Deddo Moertl, et al.
Journal of Cardiovascular Pharmacology and Therapeutics
|
October 27, 2020
Comparison of Light Transmission Aggregometry With Impedance Aggregometry in Patients on Potent P2Y12 Inhibitors
Patricia P Wadowski, Joseph Pultar, Constantin Weikert, et al.
Wiener Klinische Wochenschrift
|
August 22, 2018
Non-vitamin K antagonist oral anticoagulants in patients with an increased risk of bleeding
Thomas Gremmel, Alexander Niessner, Hans Domanovits, et al.
Cardiovascular Drugs and Therapy
|
August 27, 2020
Decreased Platelet Inhibition by Thienopyridines in Hyperuricemia
Silvia Lee, Patricia P Wadowski, Timothy Hoberstorfer, et al.
International Journal of Cardiology
|
November 15, 2011
Differential impact of cytochrome 2C9 allelic variants on clopidogrel-mediated platelet inhibition determined by five different platelet function tests
Thomas Gremmel, Christoph W Kopp, Daniela Seidinger, et al.
Page
of 14
Search research articles
Search
Showing results (81-90 of 133) with videos related to
Sort By:
Page
of 14
Research and Practice in Thrombosis and Haemostasis
|
April 3, 2025
Elderly patients are hyperresponsive to potent P2Y12 inhibitors
David Mutschlechner, Maximilian Tscharre, Patricia Pia Wadowski, et al.
Thrombosis Research
|
April 30, 2013
Response to antiplatelet therapy is independent of endogenous thrombin generation potential
Thomas Gremmel, Simon Panzer, Sabine Steiner, et al.
Platelets
|
July 14, 2010
Is TRAP-6 suitable as a positive control for platelet reactivity when assessing response to clopidogrel?
Thomas Gremmel, Andreas Calatzis, Sabine Steiner, et al.
Frontiers in Cardiovascular Medicine
|
January 8, 2021
Association of Soluble Suppression of Tumorigenesis 2 (sST2) With Platelet Activation, Monocyte Tissue Factor and Ischemic Outcomes Following Angioplasty and Stenting
Stefan Stojkovic, Svitlana Demyanets, Christoph W Kopp, et al.
Atherosclerosis
|
April 19, 2011
The P-selectin gene Pro715 allele and low levels of soluble P-selectin are associated with reduced P2Y12 adenosine diphosphate receptor reactivity in clopidogrel-treated patients
Thomas Gremmel, Christoph W Kopp, Sabine Steiner, et al.
Thrombosis Research
|
December 14, 2011
Influence of cytochrome 2C19 allelic variants on on-treatment platelet reactivity evaluated by five different platelet function tests
Thomas Gremmel, Christoph W Kopp, Deddo Moertl, et al.
Journal of Cardiovascular Pharmacology and Therapeutics
|
October 27, 2020
Comparison of Light Transmission Aggregometry With Impedance Aggregometry in Patients on Potent P2Y12 Inhibitors
Patricia P Wadowski, Joseph Pultar, Constantin Weikert, et al.
Wiener Klinische Wochenschrift
|
August 22, 2018
Non-vitamin K antagonist oral anticoagulants in patients with an increased risk of bleeding
Thomas Gremmel, Alexander Niessner, Hans Domanovits, et al.
Cardiovascular Drugs and Therapy
|
August 27, 2020
Decreased Platelet Inhibition by Thienopyridines in Hyperuricemia
Silvia Lee, Patricia P Wadowski, Timothy Hoberstorfer, et al.
International Journal of Cardiology
|
November 15, 2011
Differential impact of cytochrome 2C9 allelic variants on clopidogrel-mediated platelet inhibition determined by five different platelet function tests
Thomas Gremmel, Christoph W Kopp, Daniela Seidinger, et al.
Page
of 14